Overview
Cencora, Inc., previously known as AmerisourceBergen Corporation, is based in the United States and operates primarily within the pharmaceutical sourcing and distribution services industry. The company plays a crucial role in the global healthcare supply chain, providing drug distribution and related services designed to reduce healthcare costs and improve patient outcomes. Cencora's footprint extends across a range of projects and initiatives aimed at enhancing pharmaceutical distribution efficiency, partnering with healthcare providers, pharmacies, and pharmaceutical manufacturers. The company’s strategic initiatives include expanding its international presence, enhancing specialty distribution services, and leveraging advanced technology to streamline supply chain processes, thereby reinforcing its market position in a competitive industry landscape.
AI+ Ask Fintel’s AI assistant about Cencora, Inc..
Thinking about good questions…
Basic Stats
The share price of Cencora, Inc. as of 10 July 2025 is € 254,45 / share. The market cap (or net worth) of Cencora, Inc. as of 10 July 2025 is € 49.327,92 MM.
The Factor Analysis chart (below right) shows a view of Cencora, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 49,327.92 MM |
| EV | |
| Shares Out. | 193.86 MM |
| Earnings Date | |
| EPS (TTM) | 8.74 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.08 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | 0.08 |
| Beta | 0.71 |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.03 |
| ROE | 1.60 |
| ROIC | 0.15 |
| CROIC | -0.01 |
| OCROIC | 0.37 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | 96.82 /100 |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 5.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Cencora, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2018-07-18 | BMO Capital | Market Perform | Initiate | |
| 2018-04-27 | Credit Suisse | Neutral | Neutral | Maintains |
| 2018-04-09 | Moffett Nathanson | Buy | Initiate | |
| 2018-03-12 | Raymond James | Market Perform | Outperform | Upgrade |
| 2018-03-12 | KeyBanc | Sector Weight | Overweight | Upgrade |
| 2018-02-09 | Credit Suisse | Neutral | Neutral | Maintains |
| 2018-02-09 | Citigroup | Neutral | Neutral | Maintains |
| 2018-02-09 | Baird | Outperform | Outperform | Maintains |
| 2018-01-10 | Mitsubishi UFJ | Overweight | Initiate | |
| 2017-11-13 | Jefferies | Buy | Maintains | |
| 2017-10-27 | Citigroup | Buy | Maintains | |
| 2017-10-27 | Credit Suisse | Neutral | Maintains | |
| 2017-09-22 | William Blair | Outperform | Initiate | |
| 2017-06-30 | Credit Suisse | Neutral | Initiate | |
| 2017-05-17 | Wells Fargo | Market Perform | Initiate | |
| 2017-05-02 | KeyBanc | Overweight | Sector Weight | Downgrade |
| 2017-04-07 | Macquarie | Neutral | Initiate | |
| 2016-12-16 | KeyBanc | Sector Weight | Overweight | Upgrade |
| 2016-12-08 | Citigroup | Neutral | Buy | Upgrade |
| 2016-12-02 | Guggenheim | Buy | Initiate | |
| 2016-10-11 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2016-10-07 | Raymond James | Market Perform | Initiate | |
| 2016-10-03 | Stifel Nicolaus | Sell | Hold | Upgrade |
| 2016-08-11 | Jefferies | Buy | Maintains | |
| 2016-07-21 | SunTrust Robinson Humphrey | Buy | Initiate | |
| 2016-07-11 | Stifel Nicolaus | Hold | Sell | Downgrade |
| 2016-07-07 | Citigroup | Neutral | Maintains | |
| 2016-06-07 | Canaccord Genuity | Buy | Initiate | |
| 2016-04-29 | Stephens & Co. | Overweight | Equal-Weight | Downgrade |
| 2015-11-11 | BB&T Capital | Buy | Initiate | |
| 2015-08-25 | Jefferies | Hold | Buy | Upgrade |
| 2015-04-17 | KeyBanc | Outperform | Sector Perform | Downgrade |
| 2015-04-16 | KeyBanc | Overweight | Sector Weight | Downgrade |
| 2015-04-16 | Evercore ISI Group | Buy | Hold | Downgrade |
| 2015-02-25 | Citigroup | Neutral | Maintains | |
| 2015-02-10 | Bank of America | Neutral | Buy | Upgrade |
| 2014-12-10 | Jefferies | Hold | Maintains | |
| 2014-09-10 | Stifel Nicolaus | Hold | Initiate | |
| 2014-05-29 | Cantor Fitzgerald | Sell | Hold | Upgrade |
| 2014-04-04 | Cowen & Co. | Market Perform | Initiate | |
| 2013-12-04 | Evercore Partners | Equal-Weight | Overweight | Upgrade |
| 2013-10-22 | Jefferies | Buy | Hold | Downgrade |
| 2013-10-16 | Bank of America | Buy | Neutral | Downgrade |
| 2013-09-12 | Stephens & Co. | Equal-Weight | Initiate | |
| 2013-07-30 | McNicoll Lewis Vlak | Buy | Maintains | |
| 2013-04-22 | Evercore Partners | Overweight | Equal-Weight | Downgrade |
| 2013-04-17 | Jefferies | Buy | Maintains | |
| 2013-04-05 | Cantor Fitzgerald | Hold | Sell | Downgrade |
| 2013-04-04 | Goldman Sachs | Neutral | Initiate | |
| 2013-03-05 | Jefferies | Buy | Maintains | |
| 2013-01-15 | Baird | Outperform | Initiate | |
| 2013-01-11 | Evercore Partners | Overweight | Initiate | |
| 2012-12-12 | McNicoll Lewis Vlak | Buy | Initiate | |
| 2012-12-05 | Cantor Fitzgerald | Hold | Maintains | |
| 2012-08-23 | Cantor Fitzgerald | Buy | Hold | Downgrade |
| 2012-08-01 | Jefferies | Buy | Maintains | |
| 2012-04-30 | Jefferies | Buy | Maintains | |
| 2024-07-09 | Baird | Outperform | Outperform | Maintains |
| 2024-06-27 | Leerink Partners | Outperform | Outperform | Maintains |
| 2024-05-02 | Baird | Outperform | Outperform | Maintains |
| 2024-04-30 | Citigroup | Buy | Buy | Maintains |
| 2024-02-26 | Leerink Partners | Outperform | Initiate | |
| 2024-02-05 | Mizuho | Neutral | Neutral | Maintains |
| 2024-01-03 | Barclays | Overweight | Initiate | |
| 2023-12-14 | Wells Fargo | Equal-Weight | Initiate | |
| 2021-12-14 | Citigroup | Buy | Neutral | Downgrade |
| 2021-11-26 | RBC Capital | Sector Perform | Maintains | |
| 2021-11-16 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2021-11-16 | Credit Suisse | Outperform | Neutral | Downgrade |
| 2021-11-16 | Raymond James | Outperform | Market Perform | Downgrade |
| 2021-10-29 | Raymond James | Outperform | Maintains | |
| 2021-10-29 | Wells Fargo | Underweight | Maintains | |
| 2021-10-29 | Credit Suisse | Outperform | Maintains | |
| 2021-10-29 | Barclays | Underweight | Maintains | |
| 2021-10-26 | Evercore ISI Group | In-Line | Initiate | |
| 2021-08-25 | Barclays | Underweight | Maintains | |
| 2021-07-30 | Credit Suisse | Outperform | Maintains | |
| 2021-07-30 | Cowen & Co. | Outperform | Maintains | |
| 2021-07-30 | Raymond James | Outperform | Maintains | |
| 2021-07-30 | Wells Fargo | Underweight | Maintains | |
| 2021-04-30 | Credit Suisse | Outperform | Maintains | |
| 2021-03-12 | Mizuho | Neutral | Maintains | |
| 2021-03-12 | Evercore ISI Group | In-Line | Initiate | |
| 2021-02-05 | Credit Suisse | Outperform | Maintains | |
| 2021-02-02 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2021-01-06 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2020-12-10 | Wells Fargo | Equal-Weight | Underweight | Downgrade |
| 2020-12-03 | Mizuho | Neutral | Initiate | |
| 2020-10-30 | Credit Suisse | Neutral | Maintains | |
| 2020-08-06 | Raymond James | Market Perform | Outperform | Upgrade |
| 2020-07-15 | Barclays | Underweight | Initiate | |
| 2020-05-01 | Credit Suisse | Neutral | Maintains | |
| 2020-05-01 | Wells Fargo | Equal-Weight | Maintains | |
| 2020-04-13 | Baird | Outperform | Neutral | Downgrade |
| 2020-03-17 | Citigroup | Neutral | Buy | Upgrade |
| 2020-02-11 | Bank of America | Neutral | Underperform | Downgrade |
| 2020-02-07 | Wells Fargo | Equal-Weight | Maintains | |
| 2019-11-01 | Raymond James | Outperform | Maintains | |
| 2019-11-01 | Wells Fargo | Market Perform | Maintains | |
| 2019-07-30 | Raymond James | Outperform | Maintains | |
| 2019-07-26 | Credit Suisse | Neutral | Maintains | |
| 2019-07-10 | KeyBanc | Overweight | Sector Weight | Downgrade |
| 2019-02-11 | JP Morgan | Neutral | Underweight | Downgrade |
| 2018-12-10 | Jefferies | Buy | Hold | Downgrade |
| 2018-10-26 | RBC Capital | Outperform | Sector Perform | Downgrade |
| 2018-10-26 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2018-09-24 | Cowen & Co. | Outperform | Market Perform | Downgrade |
| 2018-09-20 | Berenberg | Buy | Initiate | |
| 2018-07-30 | Citigroup | Neutral | Neutral | Maintains |
| 2018-07-27 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2024-08-01 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-08-01 | Baird | Outperform | Outperform | Maintains |
| 2025-06-30 | Jefferies | Hold | Hold | Maintains |
| 2024-08-21 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-10-07 | Leerink Partners | Outperform | Outperform | Maintains |
| 2024-10-08 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-11-07 | Barclays | Overweight | Overweight | Maintains |
| 2024-11-07 | UBS | Buy | Buy | Maintains |
| 2024-11-07 | Baird | Outperform | Outperform | Maintains |
| 2024-11-07 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-12-13 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-01-24 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-01-29 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-04-11 | B of A Securities | Neutral | Neutral | Maintains |
| 2024-09-18 | B of A Securities | Buy | Neutral | Downgrade |
| 2024-09-06 | Baird | Outperform | Outperform | Maintains |
| 2025-07-16 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-02-06 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2025-03-14 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-04-29 | UBS | Buy | Buy | Maintains |
| 2025-08-13 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-05-08 | Citigroup | Buy | Buy | Maintains |
| 2025-05-08 | Baird | Outperform | Outperform | Maintains |
| 2025-06-03 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
